Page 36 - Cardiff Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cardiff oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cardiff Oncology Today - Breaking & Trending Today

Cardiff Oncology to Present at H.C. Wainwright Global Life Sciences Conference

Share this article
SAN DIEGO, March 3, 2021 /PRNewswire/
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced that the Company will present at the upcoming H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021. The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. ET on Tuesday, March 9, 2021. The Company will also participate in one-on-one meetings with investors during the conference.
About Cardiff Oncology, Inc. ....

Karen Oshea , Vicki Kelemen , Joyce Allaire , Cardiff Oncology Inc , Lifesci Communications , Hc Wainwright Global Life Sciences Conference , Prnewswire Cardiff Oncology Inc , Global Life Sciences Conference , Cardiff Oncology , Polo Like Kinase , Oncology Contact , கரேன் ஓஷேஆ , மகிழ்ச்சி அல்லேர் , கார்டிஃப் புற்றுநோயியல் இன்க் , ஹ்ஸீ வேந்‌ரைட் உலகளாவிய வாழ்க்கை அறிவியல் மாநாடு , உலகளாவிய வாழ்க்கை அறிவியல் மாநாடு , கார்டிஃப் புற்றுநோயியல் , புற்றுநோயியல் தொடர்பு ,

Cardiff Oncology: 4Q Earnings Snapshot

SAN DIEGO (AP) Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $6.6. ....

Zacks Investment Research , Wall Street , Automated Insights , Zacks Investment , United States , Western Europe , San Diego , Cardiff Oncology , Mc Complete State National , California State News , North America Cardiff Wales United Kingdom , F Wire , Cardiff Oncology 4q Earnings Snapshot , ஜாக்கக்ஸ் முதலீடு ஆராய்ச்சி , சுவர் தெரு , தானியங்கி நுண்ணறிவு , ஜாக்கக்ஸ் முதலீடு , ஒன்றுபட்டது மாநிலங்களில் , மேற்கு யூரோப் , சான் டியாகோ , கார்டிஃப் புற்றுநோயியல் , ம்ஸீ முழுமை நிலை தேசிய , கலிஃபோர்னியா நிலை செய்தி , வடக்கு அமெரிக்கா கார்டிஃப் வேல்ஸ் ஒன்றுபட்டது கிஂக்டம் , எஃப் கம்பி ,

Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights

Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights
News provided by
Share this article
SAN DIEGO, Feb. 25, 2021 /PRNewswire/
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced recent company highlights and financial results for the fourth quarter and full year ended December 31, 2020.
Over the last several months we achieved key clinical milestones, which provided the momentum for our successful raise of over $100 million. Together, these events have enabled us to accelerate the execution of our clinical programs and expand our pipeline to other relevant cancer indications, said Dr. Mark Erlander, chief executive officer of Cardiff Oncology. Data from our lead KRAS-mutate ....

United States , University Of Nebraska Medical Center , Karen Oshea , Mark Erlander , Vicki Kelemen , Joyce Allaire , American Society Of Hematology , Prostate Cancer Foundation Scientific , Lifesci Communications , Kansas University , Cardiff Oncology Inc , Network Development , Mikroscan Technologies Inc , Unetech Institute , Crc Program , Massachusetts Institute Of Technology , Drug Administration , Prnewswire Cardiff Oncology Inc , Afaxys Inc , Cancer Center , Perceptimed Inc , Exchange Commission , Crpc Program , Paradigm Diagnostics Inc , Norris Comprehensive Cancer Center , Mayo Clinic Cancer Centers Arizona ,

Cardiff Oncology to Present at the LifeSci Partners Precision Oncology Day

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing a drug to treat cancers with the greatest medical need. ....

Karen Oshea , Mark Erlander , Vicki Kelemen , Joyce Allaire , Cardiff Oncology Inc , Lifesci Communications , Cardiff Oncology , Lifesci Partners Precision Oncology Day , Polo Like Kinase , Oncology Contact , Chief Operating , Health Care Amp Hospitals , Small Cap , Medical Pharmaceuticals , Conference Call Announcements , கரேன் ஓஷேஆ , மகிழ்ச்சி அல்லேர் , கார்டிஃப் புற்றுநோயியல் இன்க் , கார்டிஃப் புற்றுநோயியல் , புற்றுநோயியல் தொடர்பு , தலைமை இயங்குகிறது , ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் , சிறிய தொப்பி , உயிரி தொழில்நுட்பவியல் , மருத்துவ மருந்துகள் , மாநாடு அழைப்பு அறிவிப்புகள் ,

Investegate |Tiziana Life Sci PLC Announcements | Tiziana Life Sci PLC: APPOINTMENT OF DIRECTOR

5 February 2021
NEW YORK and LONDON - February 5, 2021 (GLOBE NEWSWIRE) - Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ( Tiziana or the Company ), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr Thomas Adams, Ph.D. as an executive director.
Dr Adams will assume the position of Head of Drug Development with immediate effect and his executive role will be to manage and oversee all matters relating to the Company s pre-clinical and clinical drug development programs and associated intellectual property.
Dr Thomas H Adams (age: 78)
Dr. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside. The Board believes that Dr. Adams executive leadership and the extensive healthcare expertise he has developed makes Dr. Adams ideally qualified to serve as an additional director of the Company. ....

United States , United Kingdom , City Of , Thomas Adams , Gabriele Cerrone , Thomash Adams , Clearbridge Biophotonics Inc , Cardiff Oncology Inc , University Of California , Genta Inc , Hepion Pharmaceuticals Inc , International Inc , Tiziana Life Sciences , Company Milciclib , Head Of Drug Development , Chugai Biopharmaceuticals Inc , Redchip Companies Inc , Synergy Pharmaceuticals Inc , Danaher Corporation , Life Sciences , Drug Development , Cardiff Oncology , Chief Executive Officer , Executive Chairman , Polo Like Kinase , Hepion Pharmaceuticals ,